Latest Biomarker Stories

King of Prussia Prediabetes Treatment Center Will Attend American Diabetes Association Cycling Event. King of Prussia, PA (PRWEB) May 22, 2013 The PreDiabetes Center of King of Prussia is proud to announce its participation in the Greater Philadelphia Tour de Cure, a premier cycling event that brings together experienced cyclists and recreational riders who are passionate about stopping the spread of diabetes, a chronic disease that affects more than 25 million Americans. The Tour de...

Co-founders Hardy Hoheisel and Wolfgang Koecher Named CEO and CTO KASSEL, Germany, May 22, 2013 /PRNewswire/ -- Biozoom has created the world's first portable, handheld consumer device to use reflection spectroscopy for real-time diagnostics in humans. A technological breakthrough that some describe as a disruptive technology for the multi-billion dollar health and wellness market, the Biozoom scanner instantly and non-invasively measures certain biomarkers--including antioxidant...

The OligoScan is the latest addition to AAG Health’s line-up of state-of-the-art diagnostic testing devices which already include the research grade InBody 720 (body composition analyzer), the Korr MetaCheck (resting metabolic rate machine), the Panasonic Cardio Heart Station (arterial plaque analyzer) and the Biomarkers of Aging testing series. Miami, Florida (PRWEB) May 21, 2013 AAG Health, the leading age management and hormone optimization center located in Miami, announced today...

Pressure BioSciences' PCT Platform Enhances Study Results SOUTH EASTON, Mass., May 16, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced the publication in the journal Analytical Chemistry of a study by a team of scientists led by Dr. Bruce Kristal, Associate Professor of Surgery at Harvard Medical School and the Department of Neurosurgery at Brigham and Women's Hospital, entitled: Method Development for Fecal Lipidomics...

The Pittcon Program Committee is pleased to announce that Steven Carr, director of proteomics at the Broad Institute of MIT and Harvard, will deliver the Wallace H. Coulter Plenary Lecture at PIttcon 2014. Pittsburgh, PA (PRWEB) May 15, 2013 Dr. Carr is internationally recognized as a leader in the development of novel proteomics methods and in their application in biology and medicine. Dr. Carr and his group collaborate with scientists throughout the greater Broad community (Broad...

HOUSTON, May 15, 2013 /PRNewswire/ -- ApoCell, Inc. announced that the first prototypes of its ApoStream(TM) circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million subcontract awarded to ApoCell in Q1-2011 by SAIC-F to develop a device capable of isolating live cancer cells from small volumes of blood. While...

Collaboration connects gene expression data and physiological mechanistic model simulations that should illuminate best treatment for selected patients. San Mateo, CA (PRWEB) May 14, 2013 Entelos Holding Corp. (“Entelos” or “the Company”), a premier provider of physiological system modeling and services, and Seattle-based Institute for System Biology (ISB), the nonprofit pioneers of the systems approach to study the molecular causes of diseases, today announced the successful...

Brett Smith for redOrbit.com - Your Universe Online Many Alzheimer’s disease researchers are focused on stopping the buildup of amyloid plaques, dense protein deposits that are a telltale sign of the debilitating disease. However, a group of scientists from the Salk Institute for Biological Studies decision to think outside the box and pursue a different treatment strategy has paid off. According to their report in the journal Alzheimer’s Research and Therapy, the Salk team has...

DANVILLE, Pennsylvania, May 10, 2013 /PRNewswire/ -- Geisinger Health System announced plans to partner with Indivumed, a leading provider of services enabling individualized cancer therapy, a relationship that will afford Geisinger patients access to advanced cancer treatment and clinical trials. "Our driving mission for nearly 100 years comes from a simple mandate, 'Make it the best,'" said Glenn D. Steele Jr., M.D., Ph.D., president and chief executive officer at...

SEATTLE, May 9, 2013 /PRNewswire/ -- Adaptive Biotechnologies announced today that it has entered into a collaboration agreement with Bristol-Myers Squibb for the discovery of immunological biomarkers in oncology. (Logo: http://photos.prnewswire.com/prnh/20120103/SF28632LOGO) Under the collaboration, Adaptive will use its proprietary immune profiling assay, immunoSEQ, to identify potential biomarkers that may inform about drug response. The immunoSEQ assay uses high throughput...